AXSM vs ABVX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AXSM · Axsome Therapeutics$132.37 ▲ 1.98%
ABVX · Abivax S.A.$85.73 ▲ 1.85%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AXSM -3.9%
- ABVX -19.2%
Head to head
| Metric | AXSM | ABVX |
|---|---|---|
| Price | $132.37 | $85.73 |
| Change today | ▲ 1.98% | ▲ 1.85% |
| Market cap | $6.96B | $7.50B |
| Return, 3 months | -40.1% | -32.8% |
| Return, year to date | -27.5% | -36.4% |
| Return, 1 year | -4.2% | -18.6% |
| P/E (TTM) | -43.7 | -14.3 |
| P/B | 66.1 | 18.3 |
| P/E percentile vs own 5y | 16th | 57th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +45.5% | – |
| Net profit growth (YoY) | -7.0% | -142.6% |
| Gross margin | 93.2% | – |
| Operating margin | -23.5% | – |
| Net margin | -24.7% | – |
| Return on equity | -245.1% | -252.3% |
| Analyst target vs. price | +114.9% | +87.3% |
| Analyst buy share | 94% | 89% |
| RSI (14) | 25 | 42 |
| 30-day volatility | 40.4% | 49.2% |
| Max drawdown, 1 year | -49.1% | -50.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ABVX is the largest of the group by market value.
- AXSM has returned the most over the past year.
- AXSM carries the lowest trailing P/E.
- AXSM has been the calmest stock over the last 30 days.